Michael Krauss at Point Of Law today reports on a securities action against drugmaker Bristol-Myers Squibb in which the company won an outright dismissal of the case (”with prejudice” = cannot be filed again), but paid $300 million anyway rather than take its chances on appeal. Also at Point Of Law today: the Federal Trade Commission is throwing a conference next month on the subject of protecting consumers in class actions; and if you want a press pass to the ATLA convention, be aware that certain kinds of press are not welcome. Update Mar. 2, 2005 (judge in Bristol-Myers case slashes fees).
Related posts
In class actions
